Registration 333-293562
Underwriters: ThinkEquity LLC
Company research
Medical 21, Inc.
CIK 1673688Updated Oct 26, 2026
Filing activity
Latest filing
30 filings on record · D, S-1/A, S-1, DRS/A, DRS, D/A.
About the company
Medical 21 is a developmental-stage medical technology company dedicated to revolutionizing coronary artery bypass grafting (“CABG”) surgery. Our flagship product, the MAVERICS small-diameter synthetic regenerative graft, is an investigational device designed to serve as an alternative conduit to harvested autologous vessels. By potentially reducing or avoiding the need for traditional vessel harvesting, MAVERICS is intended to simplify the CABG procedure and decrease patient morbidity associated with additional surgical incisions. MAVERICS has not been approved by the U.S. Food and Drug Administration (“FDA”) or any foreign regulatory authority, and its safety and efficacy have not been established.
Recent filings
Show 5 more recent filings
Offerings
Filing attachments
ea025689604ex99-1_medical21.htm · S-1 · 2026-02-19
Exhibit 99.1 CONSENT OF DIRECTOR NOMINEE Medical 21, Inc. (the “Company”) is filing a Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), in connection with the initial public offering (“IPO”) of its common stock. In connection with the IPO, I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of the Company in the Registration Statement…
Read attachment ↗ea025689604ex99-2_medical21.htm · S-1 · 2026-02-19
Exhibit 99.2 CONSENT OF DIRECTOR NOMINEE Medical 21, Inc. (the “Company”) is filing a Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), in connection with the initial public offering (“IPO”) of its common stock. In connection with the IPO, I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of the Company in the Registration Statement…
Read attachment ↗